Burning Rock Biotech Debt-to-Equity Ratio Growth & History (BNR)
Burning Rock Biotech's debt-to-equity ratio was 0.08 for fiscal 2025.
View full Burning Rock Biotech company overviewBurning Rock Biotech annual debt-to-equity ratio history
| Fiscal year | Period ended | Debt-to-equity ratio | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 0.08 | −0.01 | −10.99% |
| 2024 | 2024-12-31 | 0.09 | 0.07 | +461.59% |
| 2023 | 2023-12-31 | 0.02 | −0.03 | −63.42% |
| 2022 | 2022-12-31 | 0.04 | −0.00 | −6.66% |
| 2021 | 2021-12-31 | 0.05 | 0.04 | +1442.48% |
| 2020 | 2020-12-31 | 0.00 | — | — |
Burning Rock Biotech quarterly debt-to-equity ratio
| Fiscal quarter | Period ended | Debt-to-equity ratio | Change | YoY change |
|---|---|---|---|---|
| Q4 2025 | 2025-12-31 | 0.08 | −0.01 | −10.99% |
| Q4 2024 | 2024-12-31 | 0.09 | 0.07 | +461.59% |
| Q4 2023 | 2023-12-31 | 0.02 | −0.03 | −63.42% |
| Q4 2022 | 2022-12-31 | 0.04 | −0.00 | −6.66% |
| Q2 2022 | 2022-06-30 | 0.05 | — | — |
| Q4 2021 | 2021-12-31 | 0.05 | 0.04 | +1442.48% |
| Q4 2020 | 2020-12-31 | 0.00 | — | — |
Burning Rock Biotech debt-to-equity ratio trends
Over the last five fiscal years, Burning Rock Biotech's debt-to-equity ratio increased from 0.00 to 0.08, a change of 0.08. The latest reported quarter, Q4 2025, shows 0.08.
What the debt-to-equity ratio means
The debt-to-equity ratio compares interest-bearing debt with shareholders’ equity. It helps show how much debt financing a company uses relative to its accounting equity, but useful comparison levels vary by industry.
How debt-to-equity is calculated
TickerStat calculates debt-to-equity as total interest-bearing debt divided by SEC-reported shareholders’ equity for the same balance-sheet date. Total liabilities are not treated as debt, and periods with non-positive equity are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Burning Rock Biotech source filings ↗